Drug Shortage Report for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP

Last updated on 2019-12-05 History
Report ID 96746
Drug Identification Number 01901915
Brand name LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
Common or Proper name Lidocaine Hydrochloride and Epinephrine Injection USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) LIDOCAINE HYDROCHLORIDE EPINEPHRINE
Strength(s) 20MG 0.01MG
Dosage form(s) SOLUTION
Route of administration BLOCK/INFILTRATION
Packaging size 25 x 20mL GVLMD
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-07-30
Estimated end date
Actual end date 2019-12-03
Shortage status Resolved
Updated date 2019-12-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-12-05 French Compare
v7 2019-12-05 English Compare
v6 2019-11-20 French Compare
v5 2019-11-20 English Compare
v4 2019-11-13 French Compare
v3 2019-11-13 English Compare
v2 2019-10-17 French Compare
v1 2019-10-17 English Compare

Showing 1 to 8 of 8